What Dolby Labs Stock Means For Shareholders After Formula 1 Audio Deal
- Dolby Laboratories and Apple announced that Dolby Atmos joined Dolby Vision for Formula 1 coverage on Apple TV, starting with the 2026 U.S. Grand Prix, giving U.S. Apple TV subscribers access to every race weekend in these premium formats on compatible devices.
- This expansion of Dolby Atmos and Dolby Vision into live Formula 1 coverage highlights Dolby Laboratories push to embed its premium formats deeper into subscription based sports streaming, which can influence how content partners value its licensing and technology stack.
- The next area of focus is how Dolby Laboratories wider investment story is affected by Formula 1 arriving in Dolby Atmos on Apple TV.
Dolby Laboratories Investment Narrative Recap
Owning Dolby Laboratories means believing its premium formats can keep gaining share across devices, streaming, automotive and live sports, even as older codecs and lower end hardware come under pressure. The Apple TV Formula 1 deal sits neatly in that story, but on its own it does not change the near term picture in a material way.
The key near term swing factor is whether newer licensing and usage based programs can offset softness in mobile and PC tiers that face higher component costs. The biggest risk is that higher spending on content platforms and live sports, including Formula 1, fails to pay back quickly enough and keeps margins and free cash flow under strain.
The Apple TV Formula 1 announcement is the most relevant update here because it leans directly on Dolby Atmos and Dolby Vision, which analysts already see trending toward roughly half of licensing revenue by FY26. It reinforces that Dolby Laboratories is still landing marquee content distribution deals that use its higher value formats.
At the same time, Argus cutting its target price to US$55 highlights that not everyone is comfortable with execution risk and recent revenue softness, including a quarter that declined 3%. For you as a shareholder, the question is whether these kinds of content wins arrive fast enough, and at high enough royalty rates, to outweigh cost pressure and the weaker low end device base.
What The Dolby Laboratories Forecasts Assume
Dolby Laboratories' current analyst story leans on steady expansion of the top line and a much fatter profit pool over time, rather than a sudden Formula 1 windfall on Apple TV. Consensus models point to revenue growth of 6.4% a year over the next three years and an uplift in profit margins from 16.7% today to 24.0% by year three. This would materially change how efficiently the company converts sales into earnings if it plays out.
On the earnings side, analysts forecast Dolby Laboratories to move from US$226.2 million in profit today to US$390.9 million by 2029, with earnings per share projected at US$4.36. That implies an earnings increase of about US$164.7 million over the period, which is a sizable jump that relies on both revenue growth and a richer mix of higher value formats like Atmos, Vision and newer software and patent programs.
Valuation assumptions are tied tightly to that 2029 earnings line. The consensus view uses a P/E of 22.9x applied to the US$390.9 million earnings forecast, compared with about 23.7x today and below the cited 30.7x multiple for the broader US software peer group. To discount those future cash flows back to today, the model uses an 8.6% to 8.62% rate, reflecting what analysts see as a reasonable required return for this type of business.
On revenue, the same framework points to Dolby Laboratories generating about US$1.6b in sales by 2029 if the thesis holds together. Earnings in that year are again set at US$390.9 million, which anchors the price targets and assumed valuation multiples in the current research.
Dolby Laboratories' outlook therefore combines the US$1.6b revenue and US$390.9 million earnings forecasts for 2029 with 6.4% yearly revenue growth and an earnings increase of about US$164.7 million from the current US$226.2 million base.
Discover why Dolby Laboratories' fair value indicates a 32% potential upside to its current price that could close sooner than you expect.
Exploring Other Perspectives
For a very different angle, focus on Dolby Laboratories dependence on partner ecosystems. The most optimistic analysts were already assuming US$1.6b in revenue and US$378.2 million in earnings by 2029 before this Apple TV Formula 1 move. Those forecasts could shift. Opinions can diverge widely, so explore several viewpoints before deciding what this news means for you.
Explore 3 other Dolby Laboratories fair value estimates, including one that suggests as much as 111% upside from the current price.
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so trust your own research and judgment.
- A great starting point for your Dolby Laboratories research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
- See our latest analysis for Dolby Laboratories. The report includes a comprehensive fundamental analysis summarized in a single visual called the Snowflake, making it easy to evaluate Dolby Laboratories' overall financial health at a glance.
Looking For More Investment Ideas Beyond Dolby Laboratories?
If the Dolby Laboratories story has you thinking about where else premium content, strong balance sheets, or lower risk profiles could matter, use this momentum to broaden your watchlist with other stocks that fit those themes.
- For potential value opportunities with quality fundamentals, scan the 33 high quality undervalued stocks and see which businesses line up with your return and risk expectations.
- If income is a priority, review the 8 dividend fortresses and identify companies where higher yields and payout consistency matter to the thesis.
- When capital preservation sits higher on your list, start with the 32 resilient stocks with low risk scores and focus on businesses that score better on resilience and downside protection.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com